Showing results (151-160 of 471) with videos related to
Sort By:
Pageof 48
Acta Crystallographica. Section D, Biological Crystallography|November 1, 1994
Crystal structure of a monoclinic form of dihydropteridine reductase from rat liverY Su, M M Skinner, N H Xuong, et al.Medicine and Science in Sports and Exercise|July 1, 1996
Physical and sedentary activity in school children grades 5-8: the Bogalusa Heart StudyL Myers, P K Strikmiller, L S Webber, et al.Antimicrobial Agents and Chemotherapy|January 1, 1996
Preclinical pharmacokinetics and distribution to tissue of AG1343, an inhibitor of human immunodeficiency virus type 1 proteaseB V Shetty, M B Kosa, D A Khalil, et al.The American Journal of Clinical Nutrition|June 1, 1989
A multivariate model for assessing eating patterns and their relationship to cardiovascular risk factors: the Bogalusa Heart StudyT A Nicklas, L S Webber, B Thompson, et al.The Science of the Total Environment|November 17, 2020
An approach for decomposing river water-quality trends into different flow classesQian Zhang, James S Webber, Douglas L Moyer, et al.Obesity (Silver Spring, Md.)|January 19, 2008
Development of ACTION! Wellness Program for Elementary School PersonnelLarry S Webber, Carolyn C Johnson, Donald Rose, et al.Nature|July 21, 1994
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processingK M Mohler, P R Sleath, J N Fitzner, et al.Protein Science : a Publication of the Protein Society|September 1, 1995
1H, 15N, and 13C backbone chemical shift assignments, secondary structure, and magnesium-binding characteristics of the Bacillus subtilis response regulator, Spo0F, determined by heteronuclear high-resolution NMRV A Feher, J W Zapf, J A Hoch, et al.The Journal of Biological Chemistry|December 25, 1993
The crystallographic structure of a human dihydropteridine reductase NADH binary complex expressed in Escherichia coli by a cDNA constructed from its rat homologueY Su, K I Varughese, N H Xuong, et al.Journal of Medicinal Chemistry|September 17, 1993
Preparation of substituted N-phenyl-4-aryl-2-pyrimidinamines as mediator release inhibitorsR Paul, W A Hallett, J W Hanifin, et al.Pageof 48